Microbiome Connect provides the chance to address shared challenges around innovative therapeutic development, build meaningful partnerships, and sharpen their R&D and commercial strategies. Bringing together the whole microbiome therapeutics ecosystem – from investors and large pharmaceutical companies through to the most pioneering biotechs, academic institutions and solution providers – it delivers the business-critical information you need to make strategic decisions for your organisation through in-depth case studies and expanded networking opportunities.